Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Part of paid clinical trials in Stockbridge, Georgia.

Sponsor
DexCom, Inc.
Study ID
NCT06483945
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes

Eligibility Criteria

Sex
ALL
Age
2 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Dexcom CGM G6/G6 Pro/G7 — DEVICE
    Dexcom CGM G6/G6 Pro/G7 device

Study Details

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Key Dates

Start date
Feb 28, 2024
Status verified
Jun 2024
Primary completion
Mar 31, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

Patient Reported Outcomes (PROs) [ Time Frame: 4 years ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Institute of Endocrinology Diabetes, Health & HormonesStockbridgeGeorgia30281
Shehzad Topiwala, MD
[email protected]
Palm Research CenterLas VegasNevada89148
Ellen Neylon, MSN
[email protected]
702-736-5161

Find similar trials in Stockbridge, GA

By research site
Institute of Endocrinology Diabetes, Health & Hormones· Stockbridge, GAPalm Research Center· Las Vegas, NV

Related Studies